The Indian Pharma Market grew just 1% in November 2020. During the past six months cardiac therapy had been growing in high teens; contracting now to single digits.
Overall, sales of chronic brands grew 3% while acute therapies continue to struggle, their sales being down 1%.
Volume decline for the industry continued in Nov-20. It was down 7% while blended price growth was 5%, with new-product growth of 3%.